(4-tert-Butylphenyl)glyoxylic acid, 97.0%, 500mg

2-(2,6-Dichlorophenyl)pyrrolidine, 95%, 250mg

1-Methyl-1-octylpyrrolidin-1-ium Chloride>98.0%(T)5g

1-(5-Bromo-2-methylphenyl)ethanone, 95.0%, 10g

DBD-COCl [=4-(N,N-Dimethylaminosulfonyl)-7-(N-chloroformylmethyl-N-methylamino)-2,1,3-benzoxadiazole] [for HPLC Labeling]>93.0%(T)100mg

4,6-Difluoro-2-piperazin-1-yl-1,3-benzothiazole, 95.0%, 500mg

PALMITOYLETHANOLAMIDE, 95.0%, 5g

2,2,2-Trifluoro-1-(3-(trifluoromethyl)phenyl)ethan-1-amine hydrochloride, 95%, 50mg

3-Isocyanato-2,3-dihydrothiophene 1,1-dioxide, 95.0%, 250mg

Methyl 4-methoxy-2-(methylthio)pyrimidine-5-carboxylate, 95%, 250mg

tert-Butyl (2R,5S)-2,5-diethylpiperazine-1-carboxylate, 98%, 5g

8-Bromo-3,4-dihydronaphthalen-2(1H)-one, 95.0%, 2.5g

2-(4-methoxyphenyl)-1-(2-methylpiperazin-1-yl)ethan-1-one, 95.0%, 2g